Document Classification

Section Type: METHODS

Text: Previously untreated SCLC patients were randomized to standard CDE (cyclophosphamide 1, 000 mg/m (2) and doxorubicin 45 mg/m (2) on day 1, and etoposide 100 mg/m (2) on days 1 to 3 every 3 weeks, for five cycles) or intensified CDE (cyclophosphamide 1, 250 mg/m (2) and doxorubicin 55 mg/m (2) on day 1, and etoposide 125 mg/m (2) on days 1 to 3 with granulocyte colony-stimulating factor [G-CSF] 5 micro g/kg/d on days 4 to 13 every 2 weeks, for four cycles).